Financhill
Back

Nektar Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell
33

NKTR
Nektar Therapeutics

Last Price:
1.02
Seasonality Move:
15.74%
Sell
40

LLY
Eli Lilly and

Last Price:
749.91
Seasonality Move:
3.67%
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $1.01. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $749.92. The Score for LLY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $1.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $749.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 30.88 Sell
Chaikin Money Flow: 16759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.13 - 1.41) Sell
Bollinger Bands (100): (1.18 - 1.38) Sell

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -37.76 Sell
Relative Strength Index (14 RSI): 32.45 Sell
Chaikin Money Flow: 2603304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (767.47 - 887.61) Sell
Bollinger Bands (100): (822.35 - 941.55) Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Sell
20-day SMA: 1.24 Sell
50-day SMA: 1.27 Sell
200-day SMA: 1.23 Sell
8-day EMA: 1.1 Sell
20-day EMA: 1.2 Sell
50-day EMA: 1.25 Sell
200-day EMA: 1.22 Sell

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 765.42 Sell
20-day SMA: 808.04 Sell
50-day SMA: 868.82 Sell
200-day SMA: 834.81 Sell
8-day EMA: 763.14 Sell
20-day EMA: 801.26 Sell
50-day EMA: 845.99 Sell
200-day EMA: 811.74 Sell

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.08 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):